fmoc-asn(ac3acnh-beta-glc)-oh

Modify Date: 2024-01-09 10:25:01

fmoc-asn(ac3acnh-beta-glc)-oh structure	Common Name	fmoc-asn(ac3acnh-beta-glc)-oh
	CAS Number	131287-39-3	Molecular Weight	683.65900
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₃H₃₇N₃O₁₃	Melting Point	N/A
	MSDS	USA	Flash Point	N/A

Use of fmoc-asn(ac3acnh-beta-glc)-oh

Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH (Fmoc-Asn(Ac3AcNH-beta-Glc)-OH) can be used in the synthesis of silicon-fluoride acceptor (SiFA) derivatized octreotate derivatives. SiFA-octreotate analogues, as tumor imaging agents, are useful tool for the research of positron emission tomography (PET)[1].

Name	(2S)-4-[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid
Synonym	More Synonyms

Description	Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH (Fmoc-Asn(Ac3AcNH-beta-Glc)-OH) can be used in the synthesis of silicon-fluoride acceptor (SiFA) derivatized octreotate derivatives. SiFA-octreotate analogues, as tumor imaging agents, are useful tool for the research of positron emission tomography (PET)[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others
References	[1]. Wängler C, et al. One-step ^¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET). Bioconjug Chem. 2010;21(12):2289-2296.

Molecular Formula	C₃₃H₃₇N₃O₁₃
Molecular Weight	683.65900
Exact Mass	683.23300
PSA	221.96000
LogP	2.31340
Storage condition	-15°C

RIDADR	NONH for all modes of transport

Precursor 5
CAS#:4515-24-6 [(2R,3S,4R,5R,6... CAS#:6205-69-2 2-Acetamido-3,4... CAS#:4229-38-3 2-Acetamido-2-d... CAS#:7512-17-6 N-acetyl-α-D-gl...
CAS#:129460-09-9 Fmoc-Asp-OtBu
DownStream 0